Lovastatin recalls
The FDA has published 3 recalls involving Lovastatin since 2018. The latest was reported on 14 Aug 2019. Most were for potency & assay. AVKARE has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 14 Aug 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 33%Class III 2 67%
Why lovastatin is recalled
Companies
By year
All lovastatin recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Lovastatin Tablets USP, 40 mg recalled by American Health PackagingLovastatin | American Health Packaging | Potency & Assay | Nationwide |
| Drug | CLASS III | Lovastatin Tablets USP, 40 mg recalled by Lupin PharmaceuticalsLovastatin | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Lovastatin Tablets USP, 40 mg Unit Dose recalled by AVKARE | AVKARE | Potency & Assay | Nationwide |
Should you stop taking Lovastatin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.